Please login to the form below

Not currently logged in
Email:
Password:

AMNOG

This page shows the latest AMNOG news and features for those working in and with pharma, biotech and healthcare.

Germany planning to table pricing reforms 'by the summer'

Germany planning to table pricing reforms 'by the summer'

The report proposes reforms to the AMNOG (Pharmaceutical Market Restructuring Act), which include the introduction of rebates after a sales threshold is met and suggests that only five or six new ... German Minister of Health Hermann Gröhe has suggested

Latest news

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Rare diseases: meeting the challenge Rare diseases: meeting the challenge

    SKC’s white paper ‘Orphan Drugs in Germany - lessons learned from AMNOG, best and worst practices and strategic implications’ (Kirchmann et al, 2017) offers pharma manufacturers a few pointers for successful

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    Germany: overhaul of AMNOG and extended price freeze. The German Parliament has been working for several months on the Gesetz zur Stärkung der Arzneimittelversorgung in der GKV (AM-VSG; Act to ... Strengthen Pharmaceutical Supply in the Statutory Health

  • Cost containment and the German market Cost containment and the German market

    In 2011 the Pharmaceutical Market Restructuring Act (AMNOG) was adopted - a strong regulating and much-discussed instrument for the moderation of price increases caused by recently approved products.

  • The price is right? The price is right?

    The passing of Arzneimittelmarktneuordnungsgesetz (AMNOG), the Pharmaceutical Market Reorganisation Act, in 2010 introduced new regulations around the reimbursement of drugs within the German healthcare system.

  • Making savings from European drugs budgets Making savings from European drugs budgets

    AMNOG. Germany is the largest pharma market in Europe and one of the strongest economies in the Eurozone, but it too has had to make deep cuts into its medicines bill. ... This has been done through the 2011 law known as AMNOG, which changed the way

More from intelligence
Approximately 5 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Extension for head of Germany’s VFA Extension for head of Germany’s VFA

    She has led the industry voice during an unsettled time for pharma in Germany with many companies critical of the AMNOG system of drug reimbursement introduced in 2010, which has seen

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Oncology drugs under AMNOG

    The AMNOG early benefit assessment process in Germany is now over three years old and as tweaks are made to regulations and manufacturers gain more familiarity with the process we look ... With the advent of the AMNOG assessment, manufacturers face new

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics